Rancho Cucamonga, CA, United States of America

Mary Zi-Ping Luo

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 78(Granted Patents)


Location History:

  • South El Monte, CA (US) (2002)
  • Rancho Cucamonga, CA (US) (2002 - 2007)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Mary Zi-Ping Luo: Innovator in Pharmaceutical Aerosol Formulations

Introduction

Mary Zi-Ping Luo is a prominent inventor based in Rancho Cucamonga, California. She has made significant contributions to the field of pharmaceutical aerosol formulations, holding a total of four patents. Her work focuses on improving the delivery and efficacy of medicinal products, particularly in respiratory treatments.

Latest Patents

Mary's latest patents include an albuterol aerosol suspension formulation designed for oral inhalation. This formulation utilizes a high amount of green propellant hydrofluoroolefin (HFO) and is free of co-solvents, such as ethanol and glycerol. Another notable patent involves pharmaceutical aerosol formulations containing pre-micronized albuterol sulfate, which also employs a high amount of green propellant trans-1,3,3,3-tetrafluoropropene (HFO-1234ze(E)). These formulations are designed to provide efficient delivery of albuterol particles into patients' respiratory tracts, ensuring high efficacy, improved safety, and a low global warming potential.

Career Highlights

Mary Zi-Ping Luo is currently associated with Amphastar Pharmaceuticals, Inc., where she continues to innovate in the field of pharmaceutical formulations. Her work has been instrumental in developing products that prioritize both patient safety and environmental sustainability.

Collaborations

Mary collaborates with notable colleagues, including Jack Yongfeng Zhang and Frank Zhishi Xia, who contribute to her research and development efforts.

Conclusion

Mary Zi-Ping Luo exemplifies the spirit of innovation in the pharmaceutical industry, with her groundbreaking work in aerosol formulations significantly impacting patient care and environmental considerations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…